Development of a Clickable Bimodal Fluorescent/PET Probe for in Vivo Imaging

Overview

Journal EJNMMI Res

Date 2015 Aug 20

PMID 26285667

Citations 15

Authors

Andreas Paulus

Pooja Desai

Brandon Carney

Giuseppe Carlucci

Thomas Reiner

Christian Brand

Wolfgang A Weber

Affiliations

Soon will be listed here.

Abstract

Background: Fluorescent imaging agents are becoming evermore important in preclinical and clinical research. They do, however, suffer from poor tissue penetration, which makes optical fluorescence imaging incompatible with whole-body imaging techniques. The design of novel bimodal PET active and fluorescent tracers could therefore combine the benefits of optical imaging with radioactively labeled imaging probes. Herein, we report the synthesis and evaluation of a clickable (18)F-labeled fluorescent dye.

Methods: An azide-modified BODIPY-Fl dye could be successfully radio-labeled with (18)F using an (18)F/(19)F exchange reaction of the boron-fluoride core of the BODIPY dye to yield a clickable bimodal PET/fluorescent imaging tool. In vitro as well as in vivo imaging (PET/fluorescence) using a bombesin analog was conducted to study the applicability of the dual-modality imaging probe.

Results: We use the radio-labeled small molecule, (18)F-BODIPY-azide to label site-specifically different targeted peptides, based on a standard modular labeling protocol. Following the synthesis of a bimodal bombesin analog, we determine the peptide tracer's performance in vitro and in vivo, exploring both the optical as well as PET imaging capabilities.

Conclusion: This versatile methodology has the potential to have a transformational impact on (18)F radiotracer synthesis, opening the door for rapid screening of novel-labeled peptide tracers, both on the cellular (optical) as well as whole-body (PET) level.

Citing Articles

Automated radiosynthesis and in vivo evaluation of F-labeled analog of the photosensitizer ADPM06 for planning photodynamic therapy.

Kawamura K, Yamasaki T, Fujinaga M, Kokufuta T, Zhang Y, Mori W EJNMMI Radiopharm Chem. 2023; 8(1):14.

PMID: 37458904 PMC: 10352184. DOI: 10.1186/s41181-023-00199-y.

Efforts toward PET-Activatable Red-Shifted Silicon Rhodamines and Silicon Pyronine Dyes.

Kramer C, Kanagasundaram T, Matthias J, Kopka K Pharmaceuticals (Basel). 2023; 16(3).

PMID: 36986500 PMC: 10053042. DOI: 10.3390/ph16030401.

Fluorinated Protein and Peptide Materials for Biomedical Applications.

Monkovic J, Gibson H, Sun J, Montclare J Pharmaceuticals (Basel). 2022; 15(10).

PMID: 36297312 PMC: 9609677. DOI: 10.3390/ph15101201.

A CD10-OGP Membrane Peptolytic Signaling Axis in Fibroblasts Regulates Lipid Metabolism of Cancer Stem Cells via SCD1.

Yu S, Lu Y, Su A, Chen J, Li J, Zhou B Adv Sci (Weinh). 2021; 8(19):e2101848.

PMID: 34363355 PMC: 8498877. DOI: 10.1002/advs.202101848.

Solid-phase fluorescent BODIPY-peptide synthesis dipyrrin construction.

Wu Y, Tam W, Chau H, Kaur S, Thor W, Aik W Chem Sci. 2021; 11(41):11266-11273.

PMID: 34094367 PMC: 8162834. DOI: 10.1039/d0sc04849f.

References

Huang M, Xiong C, Lu W, Zhang R, Zhou M, Huang Q . Dual-modality micro-positron emission tomography/computed tomography and near-infrared fluorescence imaging of EphB4 in orthotopic glioblastoma xenograft models. Mol Imaging Biol. 2013; 16(1):74-84. PMC: 3947091. DOI: 10.1007/s11307-013-0674-3. View

Keliher E, Klubnick J, Reiner T, Mazitschek R, Weissleder R . Efficient acid-catalyzed (18) F/(19) F fluoride exchange of BODIPY dyes. ChemMedChem. 2014; 9(7):1368-73. PMC: 4145401. DOI: 10.1002/cmdc.201300506. View

Zanzonico P . Principles of nuclear medicine imaging: planar, SPECT, PET, multi-modality, and autoradiography systems. Radiat Res. 2012; 177(4):349-64. DOI: 10.1667/rr2577.1. View

Emmetiere F, Irwin C, Viola-Villegas N, Longo V, Cheal S, Zanzonico P . (18)F-labeled-bioorthogonal liposomes for in vivo targeting. Bioconjug Chem. 2013; 24(11):1784-9. PMC: 3903177. DOI: 10.1021/bc400322h. View

Carlucci G, Carney B, Brand C, Kossatz S, Irwin C, Carlin S . Dual-Modality Optical/PET Imaging of PARP1 in Glioblastoma. Mol Imaging Biol. 2015; 17(6):848-55. PMC: 4609241. DOI: 10.1007/s11307-015-0858-0. View

Keliher E, Reiner T, Thurber G, Upadhyay R, Weissleder R . Efficient F-Labeling of Synthetic Exendin-4 Analogues for Imaging Beta Cells. ChemistryOpen. 2013; 1(4):177-183. PMC: 3758109. DOI: 10.1002/open.201200014. View

Li Z, Lin T, Liu S, Huang C, Hudnall T, Gabbai F . Rapid aqueous [18F]-labeling of a bodipy dye for positron emission tomography/fluorescence dual modality imaging. Chem Commun (Camb). 2011; 47(33):9324-6. DOI: 10.1039/c1cc13089g. View

Sun Y, Ma X, Cheng K, Wu B, Duan J, Chen H . Strained cyclooctyne as a molecular platform for construction of multimodal imaging probes. Angew Chem Int Ed Engl. 2015; 54(20):5981-4. DOI: 10.1002/anie.201500941. View

Wieser G, Mansi R, Grosu A, Schultze-Seemann W, Dumont-Walter R, Meyer P . Positron emission tomography (PET) imaging of prostate cancer with a gastrin releasing peptide receptor antagonist--from mice to men. Theranostics. 2014; 4(4):412-9. PMC: 3936293. DOI: 10.7150/thno.7324. View

10.

Lee S, Xie J, Chen X . Peptide-based probes for targeted molecular imaging. Biochemistry. 2010; 49(7):1364-76. PMC: 2829605. DOI: 10.1021/bi901135x. View

11.

Brand C, Abdel-Atti D, Zhang Y, Carlin S, Clardy S, Keliher E . In vivo imaging of GLP-1R with a targeted bimodal PET/fluorescence imaging agent. Bioconjug Chem. 2014; 25(7):1323-30. PMC: 4215873. DOI: 10.1021/bc500178d. View

12.

Mansi R, Wang X, Forrer F, Waser B, Cescato R, Graham K . Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours. Eur J Nucl Med Mol Imaging. 2010; 38(1):97-107. DOI: 10.1007/s00259-010-1596-9. View

13.

Liu S, Li D, Huang C, Yap L, Park R, Shan H . Efficient construction of PET/fluorescence probe based on sarcophagine cage: an opportunity to integrate diagnosis with treatment. Mol Imaging Biol. 2012; 14(6):718-24. DOI: 10.1007/s11307-012-0557-z. View

14.

Liu S, Lin T, Li D, Leamer L, Shan H, Li Z . Lewis acid-assisted isotopic 18F-19F exchange in BODIPY dyes: facile generation of positron emission tomography/fluorescence dual modality agents for tumor imaging. Theranostics. 2013; 3(3):181-9. PMC: 3590587. DOI: 10.7150/thno.5984. View

15.

Kossatz S, Behe M, Mansi R, Saur D, Czerney P, Kaiser W . Multifactorial diagnostic NIR imaging of CCK2R expressing tumors. Biomaterials. 2013; 34(21):5172-80. DOI: 10.1016/j.biomaterials.2013.03.073. View

16.

Reiner T, Kohler R, Liew C, Hill J, Gaglia J, Kulkarni R . Near-infrared fluorescent probe for imaging of pancreatic beta cells. Bioconjug Chem. 2010; 21(7):1362-8. PMC: 2912453. DOI: 10.1021/bc100184w. View

17.

Hendricks J, Keliher E, Wan D, Hilderbrand S, Weissleder R, Mazitschek R . Synthesis of [18F]BODIPY: bifunctional reporter for hybrid optical/positron emission tomography imaging. Angew Chem Int Ed Engl. 2012; 51(19):4603-6. PMC: 3343182. DOI: 10.1002/anie.201107957. View

18.

Zhang H, Abiraj K, Thorek D, Waser B, Smith-Jones P, Honer M . Evolution of bombesin conjugates for targeted PET imaging of tumors. PLoS One. 2012; 7(9):e44046. PMC: 3443097. DOI: 10.1371/journal.pone.0044046. View

19.

Clardy S, Keliher E, Mohan J, Sebas M, Benoist C, Mathis D . Fluorescent exendin-4 derivatives for pancreatic β-cell analysis. Bioconjug Chem. 2013; 25(1):171-7. PMC: 4016126. DOI: 10.1021/bc4005014. View

20.

Adochite R, Moshnikova A, Carlin S, Guerrieri R, Andreev O, Lewis J . Targeting breast tumors with pH (low) insertion peptides. Mol Pharm. 2014; 11(8):2896-905. PMC: 4123937. DOI: 10.1021/mp5002526. View